Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to confirm the efficacy of eplivanserin 5mg/day on sleep maintenance
of patients with primary insomnia using night polysomnography recordings over a 6-week
treatment period corresponding to a stabilization of improvement of sleep.